West Pharmaceutical Services, Inc. (WST)

WST Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	28,030	19,795	23,723	26,053	17,424	34,744
Market Cap Growth	30.98%	-16.56%	-8.95%	49.53%	-49.85%	65.89%
Enterprise Value	27,911	19,469	23,540	25,461	16,995	34,372
Last Close Price	398.29	274.50	325.74	349.33	232.94	463.09

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	51.00	40.09	48.15	43.91	29.74	52.50
Forward PE	42.99	36.69	45.90	42.23	34.84	53.55
PS Ratio	8.43	6.44	8.20	8.83	6.04	12.27
PB Ratio	9.38	6.23	8.84	9.04	6.49	14.88
P/TBV Ratio	9.75	6.47	9.25	9.45	6.81	15.78
P/FCF Ratio	64.16	42.22	85.83	62.86	39.65	105.09
P/OCF Ratio	42.33	26.23	36.31	33.55	24.07	59.49
PEG Ratio	2.76	3.06	5.25	5.39	2.31	2.37

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	8.39	6.33	8.14	8.63	5.89	12.14
EV/EBITDA Ratio	30.60	24.03	31.43	30.19	19.22	38.58
EV/EBIT Ratio	38.19	30.48	39.66	36.05	22.25	44.72
EV/FCF Ratio	63.88	41.52	85.17	61.43	38.68	103.97

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.11	0.10	0.11	0.11	0.12	0.14
Debt / EBITDA Ratio	0.33	0.38	0.39	0.35	0.35	0.36
Debt / FCF Ratio	0.72	0.70	1.11	0.75	0.72	0.98
Net Debt / Equity Ratio	-0.04	-0.15	-0.07	-0.19	-0.21	-0.19
Net Debt / EBITDA Ratio	-0.13	-0.57	-0.24	-0.65	-0.65	-0.49
Net Debt / FCF Ratio	-0.27	-0.99	-0.65	-1.31	-1.31	-1.32
Asset Turnover	0.83	0.78	0.77	0.79	0.83	0.93
Inventory Turnover	4.84	4.80	4.67	4.28	4.41	4.73
Quick Ratio	1.82	2.10	1.93	2.07	2.73	2.13
Current Ratio	2.82	3.02	2.80	2.88	3.70	2.93
Return on Equity (ROE)	19.09%	16.86%	17.71%	21.32%	23.34%	31.59%
Return on Assets (ROA)	11.38%	10.09%	9.93%	11.86%	13.78%	15.73%
Return on Invested Capital (ROIC)	20.57%	19.66%	20.14%	26.35%	31.89%	38.14%
Return on Capital Employed (ROCE)	21.30%	17.70%	19.20%	22.40%	24.70%	28.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.96%	2.49%	2.08%	2.28%	3.36%	1.91%
FCF Yield	1.56%	2.37%	1.17%	1.59%	2.52%	0.95%
Dividend Yield	0.26%	0.31%	0.25%	0.22%	0.31%	0.15%
Payout Ratio	11.78%	12.40%	12.00%	9.61%	9.23%	7.72%
Buyback Yield / Dilution	1.16%	1.36%	2.13%	0.66%	0.66%	-0.66%
Total Shareholder Return	1.42%	1.67%	2.37%	0.88%	0.97%	-0.51%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error